REPORT: See what’s under construction in U.S. shipyards — download the 2025 Construction Survey. → Click Here

Spruce Biosciences to Participate in the RBC Capital Markets Global Healthcare Conference

Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that Richard King, Chief Executive Officer, will participate in a virtual fireside chat at the RBC Capital Markets Global Healthcare Conference on May 19, 2021 at 5:25pm EDT.

Interested parties can access the live webcast for the conference from the Events section of the company’s investor relations website at https://investors.sprucebiosciences.com. An archived replay of the webcast will be available after the conclusion of the live presentation for approximately 30 days.

About Spruce Biosciences

Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet need. Spruce is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy for patients suffering from classic congenital adrenal hyperplasia (CAH). Classic CAH is a serious and life-threatening disease with no known novel therapies approved in approximately 50 years. Spruce is also developing tildacerfont for women suffering from a rare form of polycystic ovary syndrome (PCOS) with primary adrenal androgen excess, representing 3-5% of females with PCOS (estimated to be 150,000 to 200,000 patients in the United States). To learn more, visit www.sprucebiosciences.com and follow us on Twitter @Spruce_Bio, LinkedIn, Facebook and YouTube.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  218.70
-3.33 (-1.50%)
AAPL  260.02
-2.75 (-1.05%)
AMD  238.98
+0.95 (0.40%)
BAC  51.10
-0.42 (-0.81%)
GOOG  255.40
+4.06 (1.62%)
META  739.42
+6.15 (0.84%)
MSFT  523.25
+5.60 (1.08%)
NVDA  182.69
+1.53 (0.84%)
ORCL  275.18
+0.03 (0.01%)
TSLA  440.79
-1.81 (-0.41%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.